[{"address1": "11400 West Olympic Boulevard", "address2": "Suite 200", "city": "Los Angeles", "state": "CA", "zip": "90064", "country": "United States", "phone": "310 651 8041", "website": "https://www.immixbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ilya  Rachman M.B.A., M.D., MBA, Ph.D.", "age": 51, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 669000, "exercisedValue": 0, "unexercisedValue": 1846232}, {"maxAge": 1, "name": "Mr. Gabriel  Morris B.A.", "age": 37, "title": "CFO & Director", "yearBorn": 1987, "fiscalYear": 2023, "totalPay": 669000, "exercisedValue": 0, "unexercisedValue": 3188312}, {"maxAge": 1, "name": "Dr. Graham  Ross FFPM, M.D.", "age": 64, "title": "Chief Medical Officer & Head of Clinical Development", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 104423, "exercisedValue": 0, "unexercisedValue": 55346}, {"maxAge": 1, "name": "Mr. Sean  Senn J.D., M.B.A., M.Sc., MBA, MSc", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.", "age": 77, "title": "Scientific Co-Founder", "yearBorn": 1947, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nandan  Oza B.S.", "age": 62, "title": "Head of Chemistry, Manufacturing & Control", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Marks MBBS, Ph.D.", "title": "Chief Medical Officer of Cell Therapy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerhard  Bauer", "title": "Head of Cell Therapy Manufacturing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.78, "open": 1.8, "dayLow": 1.7, "dayHigh": 1.819, "regularMarketPreviousClose": 1.78, "regularMarketOpen": 1.8, "regularMarketDayLow": 1.725, "regularMarketDayHigh": 1.819, "payoutRatio": 0.0, "beta": 0.228, "forwardPE": -3.2363634, "volume": 68684, "regularMarketVolume": 68688, "averageVolume": 157001, "averageVolume10days": 83870, "averageDailyVolume10Day": 83870, "bid": 1.77, "ask": 1.81, "bidSize": 1, "askSize": 1, "marketCap": 48963528, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 3.799, "fiftyDayAverage": 2.09846, "twoHundredDayAverage": 1.985495, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 30362218, "profitMargins": 0.0, "floatShares": 17772134, "sharesOutstanding": 27507600, "sharesShort": 335267, "sharesShortPriorMonth": 356527, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.012200001, "heldPercentInsiders": 0.40098, "heldPercentInstitutions": 0.12157, "shortRatio": 3.26, "shortPercentOfFloat": 0.0388, "impliedSharesOutstanding": 27507600, "bookValue": 0.639, "priceToBook": 2.7856026, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -21890826, "trailingEps": -0.84, "forwardEps": -0.55, "enterpriseToEbitda": -1.317, "52WeekChange": -0.4144737, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 1.78, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 19690432, "totalCashPerShare": 0.716, "ebitda": -23047998, "totalDebt": 1089055, "quickRatio": 3.3, "currentRatio": 3.466, "debtToEquity": 6.205, "returnOnAssets": -0.60545, "returnOnEquity": -1.18504, "freeCashflow": -8295194, "operatingCashflow": -15796341, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMMX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1740169718, "exchange": "NCM", "messageBoardId": "finmb_417356223", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.78, "shortName": "Immix Biopharma, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639665000000, "regularMarketChange": 0.0, "regularMarketDayRange": "1.725 - 1.819", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 157001, "fiftyTwoWeekLowChange": 0.52, "fiftyTwoWeekLowChangePercent": 0.4126984, "fiftyTwoWeekRange": "1.26 - 3.799", "fiftyTwoWeekHighChange": -2.019, "fiftyTwoWeekHighChangePercent": -0.53145564, "fiftyTwoWeekChangePercent": -41.447372, "earningsTimestampStart": 1743105600, "earningsTimestampEnd": 1743451200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.84, "epsForward": -0.55, "epsCurrentYear": -0.795, "priceEpsCurrentYear": -2.2389936, "longName": "Immix Biopharma, Inc.", "marketState": "REGULAR", "fiftyDayAverageChange": -0.31846, "fiftyDayAverageChangePercent": -0.15175891, "twoHundredDayAverageChange": -0.205495, "twoHundredDayAverageChangePercent": -0.10349812, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-16", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Immix Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]